Dopaminergic Basis of Spatial Deficits in Early Parkinson's Disease
Date
2021-06-24Journal
Cerebral Cortex CommunicationsPublisher
Oxford University PressType
Article
Metadata
Show full item recordAbstract
Dopaminergic mechanisms regulating cognitive and motor control were evaluated comparing visuoperceptual and perceptuomotor functions in Parkinson's disease (PD). The performance of PD patients (n = 40) was contrasted with healthy controls (n = 42) across two separate visits (on and off dopaminergic medications) on computerized tasks of perception and aiming to a target at variable stimulus lengths (4, 8, 12 cm). Novel visuoperceptual tasks of length equivalence and width interval estimations without motor demands were compared with tasks estimating spatial deviation in movement termination. The findings support the presence of spatial deficits in early PD, more pronounced with increased discrimination difficulty, and with shorter stimulus lengths of 4 cm for both visuoperceptual and perceptumotor functions. Dopaminergic medication had an adverse impact on visuoperceptual accuracy in particular for length equivalence estimations, in contrast with dopaminergic modulation of perceptuomotor functions that reduced angular displacements toward the target. The differential outcomes for spatial accuracy in perception versus movement termination in PD are consistent with involvement of the direct pathway and models of progressive loss of dopamine through corticostriatal loops. Future research should develop validated and sensitive standardized tests of perception and explore dopaminergic selective deficits in PD to optimize medication titration for motor and cognitive symptoms of the disease.Rights/Terms
Published by Oxford University Press 2021.Identifier to cite or link to this item
http://hdl.handle.net/10713/17085ae974a485f413a2113503eed53cd6c53
10.1093/texcom/tgab042
Scopus Count
Collections
Related articles
- Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
- Authors: Michely J, Barbe MT, Hoffstaedter F, Timmermann L, Eickhoff SB, Fink GR, Grefkes C
- Issue date: 2012 Aug
- Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
- Authors: Huang YT, Georgiev D, Foltynie T, Limousin P, Speekenbrink M, Jahanshahi M
- Issue date: 2015 Aug
- Dopaminergic contributions to distance estimation in Parkinson's disease: a sensory-perceptual deficit?
- Authors: Ehgoetz Martens KA, Ellard CG, Almeida QJ
- Issue date: 2013 Jul
- Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease.
- Authors: Mollion H, Ventre-Dominey J, Dominey PF, Broussolle E
- Issue date: 2003
- Impact of dopamine and cognitive impairment on neural reactivity to facial emotion in Parkinson's disease.
- Authors: Dan R, Růžička F, Bezdicek O, Roth J, Růžička E, Vymazal J, Goelman G, Jech R
- Issue date: 2019 Nov